A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

NCT04958226 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumour

Interventions

DRUG: Capivasertib
DRUG: Midazolam

Sponsor

AstraZeneca